Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Total Non-Current Liabilities: 2010-2025

Historic Total Non-Current Liabilities for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $18.5 million.

  • Cryo Cell International's Total Non-Current Liabilities rose 590.63% to $18.5 million in Q3 2025 from the same period last year, while for Aug 2025 it was $18.5 million, marking a year-over-year increase of 590.63%. This contributed to the annual value of $21.6 million for FY2024, which is 352.54% up from last year.
  • Cryo Cell International's Total Non-Current Liabilities amounted to $18.5 million in Q3 2025, which was up 590.63% from $21.8 million recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Total Non-Current Liabilities peaked at $29.8 million during Q1 2021, and registered a low of $15.7 million during Q2 2022.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $19.7 million (2023), whereas its average is $20.2 million.
  • In the last 5 years, Cryo Cell International's Total Non-Current Liabilities surged by 351058.05% in 2021 and then plummeted by 4509.23% in 2022.
  • Over the past 5 years, Cryo Cell International's Total Non-Current Liabilities (Quarter) stood at $21.1 million in 2021, then decreased by 7.56% to $19.5 million in 2022, then rose by 7.1% to $20.9 million in 2023, then grew by 3.53% to $21.6 million in 2024, then fell by 14.57% to $18.5 million in 2025.
  • Its last three reported values are $18.5 million in Q3 2025, $21.8 million for Q2 2025, and $21.7 million during Q1 2025.